Literature DB >> 28078982

Phytochemicals - A Novel and Prominent Source of Anti-cancer Drugs Against Colorectal Cancer.

Ravikiran Mahadevappa1, Hang Fai Kwok1.   

Abstract

BACKGROUND & AIM: Colorectal cancer (CRC) is a malignant disease whose incidence and mortality rates are greatly influenced by environmental factors. Under-treatment of CRC such as a poor diagnostic evaluation, less aggressive surgery, less intensive chemotherapy results in metastasizing of the primary tumor cells and recurrence of cancer. Prolonged chemotherapy treatment against cancer is hazardous to the patients, which also limits its use in cancer therapy. Current research in developing a novel anti-cancer agent, direct towards finding a better antimetastatic and an anti-invasive drug with reduced side effects. METHOD &
RESULTS: In this direction, plant derived chemical compounds or phytochemical act as a prominent source of new compounds for drug development. Phytochemicals have a multi-action and a multi-target capacity, and has gained attention among the research communities from last two decades. Epidemiological study shows a direct relationship between a diet and CRC development. A diet rich in plant based products such as vegetables, fruits and cereals is known to prevent CRC development. This review is an effort to explore more about the potential phytochemicals in CRC prevention and also in CRC treatment.
CONCLUSION: Here, we have discussed few phytochemicals actively used in CRC research and are in clinical trials against CRC. We have explored more on some of these phytochemicals which can act as a source for new drug or can act as a lead compound for further modifications during the drug development against cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Colorectal cancer; Withaferin A; anti-cancer; anti-oxidants; curcumin; phytochemicals; resveratrol

Mesh:

Substances:

Year:  2017        PMID: 28078982     DOI: 10.2174/1386207320666170112141833

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  5 in total

Review 1.  Resveratrol-loaded nanomedicines for cancer applications.

Authors:  Manjusha Annaji; Ishwor Poudel; Sai H S Boddu; Robert D Arnold; Amit K Tiwari; R Jayachandra Babu
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-02

2.  Anticancer activity of calyx of Diospyros kaki Thunb. through downregulation of cyclin D1 via inducing proteasomal degradation and transcriptional inhibition in human colorectal cancer cells.

Authors:  Su Bin Park; Gwang Hun Park; Hun Min Song; Ho-Jun Son; Yurry Um; Hyun-Seok Kim; Jin Boo Jeong
Journal:  BMC Complement Altern Med       Date:  2017-09-05       Impact factor: 3.659

Review 3.  Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms.

Authors:  Hongzhang Ge; Chao Xu; Haitao Chen; Ling Liu; Lei Zhang; Changhong Wu; Yi Lu; Qinghua Yao
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

4.  Destruxin B Suppresses Drug-Resistant Colon Tumorigenesis and Stemness Is Associated with the Upregulation of miR-214 and Downregulation of mTOR/β-Catenin Pathway.

Authors:  Szu-Yuan Wu; Yan-Jiun Huang; Yew-Min Tzeng; Chi-Ying F Huang; Michael Hsiao; Alexander T H Wu; Tse-Hung Huang
Journal:  Cancers (Basel)       Date:  2018-09-25       Impact factor: 6.639

Review 5.  Chemical diversity of dietary phytochemicals and their mode of chemoprevention.

Authors:  Srimanta Patra; Rabindra Nayak; Suryamani Patro; Biswajita Pradhan; Brundaban Sahu; Chhandashree Behera; Sujit Kumar Bhutia; Mrutyunjay Jena
Journal:  Biotechnol Rep (Amst)       Date:  2021-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.